a Hepatic Surgery Center , Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , Hubei , China.
b Department of Biliary and Pancreatic Surgery , Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , Hubei , China.
Cancer Biol Ther. 2018 May 4;19(5):381-390. doi: 10.1080/15384047.2018.1423920. Epub 2018 Feb 12.
ABSTRACTS This research aimed to explore effects of SIX1 and DACH1 on hepatocellular carcinoma (HCC) cell proliferation, apoptosis and cell cycle. Fifty paired hepatocellular carcinoma tissues were screened for differentially expressed genes. SIX1 and DACH1 expressions were subjected to qRT-PCR and western blot in tumor tissues and cells. The knockdown efficiency of siRNAs and transfection efficiency of cDNAs and siRNAs were validated by qRT-PCR and western blot as well. Then colony formation assay and flow cytometry were applied to observe cell proliferation, cell apoptosis and cell cycle changes. Immunofluorescence co-localization and immunoprecipitation were used to analyze the interaction between proteins which was quantified using western blot. Effects of SIX1 and DACH1 on tumor growth and their expressions in tumors were confirmed in vitro in nude mice model. Results of these experiments showed that SIX1 was overexpressed while DACH1 was suppressed in HCC tissues and cells. The suppression of SIX1 and overexpression of DACH1 not only inhibited cell proliferation, but also induced cell apoptosis and arrested cell cycle in G2/M phase compared with control group. Results of immunofluorescence co-localization suggested that SIX1, p53 and DACH1 were significantly overlapped. Immunoprecipitation showed that DACH1 (marked with Flag tag) could pull down p53 and SIX1, but SIX1 (marked with His tag) could only pull down DACH1, which indicated that an indirect regulation between SIX1 and p53. Validated with western blot afterwards, DACH1 overexpression suppressed tumorigenesis in vivo by up-regulating p53 expression while SIX1 overexpression accelerated tumor growth by down-regulating p53 expression. Therefore, the decrease of SIX1 facilitated the expression of DACH1, thus activated the expression of p53 and suppressed the progression of HCC both in vitro and in vivo.
摘要 本研究旨在探索 SIX1 和 DACH1 对肝细胞癌(HCC)细胞增殖、凋亡和细胞周期的影响。筛选了 50 对肝癌组织中的差异表达基因。在肿瘤组织和细胞中进行 qRT-PCR 和 Western blot 检测 SIX1 和 DACH1 的表达。通过 qRT-PCR 和 Western blot 验证了 siRNAs 的敲低效率和 cDNA 和 siRNAs 的转染效率。然后通过集落形成实验和流式细胞术观察细胞增殖、细胞凋亡和细胞周期变化。免疫荧光共定位和免疫沉淀用于分析蛋白质之间的相互作用,并通过 Western blot 对其进行定量。在体外裸鼠模型中验证了 SIX1 和 DACH1 对肿瘤生长的影响及其在肿瘤中的表达。这些实验结果表明,SIX1 在 HCC 组织和细胞中过表达,而 DACH1 则受到抑制。与对照组相比,抑制 SIX1 的表达和过表达 DACH1 不仅抑制了细胞增殖,还诱导了细胞凋亡,并将细胞周期阻滞在 G2/M 期。免疫荧光共定位的结果表明,SIX1、p53 和 DACH1 明显重叠。免疫沉淀表明,DACH1(用 Flag 标记)可以拉下 p53 和 SIX1,但 SIX1(用 His 标记)只能拉下 DACH1,这表明 SIX1 和 p53 之间存在间接调节。随后用 Western blot 验证,DACH1 的过表达通过上调 p53 表达抑制体内肿瘤发生,而 SIX1 的过表达通过下调 p53 表达加速肿瘤生长。因此,SIX1 的减少促进了 DACH1 的表达,从而激活了 p53 的表达,在体内和体外均抑制了 HCC 的进展。